Cefotaxime

Cefotaxime is a third-generation Cephalosporin antibiotic. It was first patented in 1976 and came into medical use in 1980. Cefotaxime is used to treat a variety of bacterial infections, including those caused by Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae, Neisseria gonorrhoeae, and others.
Chemistry[edit]
Cefotaxime is a semi-synthetic, beta-lactam antibiotic, which is resistant to most beta-lactamases. It is derived from Cephalosporin C, a naturally occurring antibiotic produced by the fungus Acremonium. Cefotaxime works by inhibiting the synthesis of the bacterial cell wall, leading to cell death.
Pharmacology[edit]
Cefotaxime is administered either by intravenous or intramuscular injection. It is metabolized in the body and excreted in the urine. The half-life of cefotaxime is approximately one hour in adults.
Clinical Use[edit]
Cefotaxime is used to treat a wide range of infections, including pneumonia, meningitis, gonorrhea, and infections of the skin, urinary tract, and abdomen. It is also used for surgical prophylaxis in patients undergoing abdominal or pelvic surgery.
Side Effects[edit]
Common side effects of cefotaxime include rash, diarrhea, and changes in white blood cell count. Serious side effects may include Clostridium difficile infection, allergic reactions, and seizures.
Resistance[edit]
Resistance to cefotaxime and other cephalosporins can occur through several mechanisms, including the production of beta-lactamase enzymes, alteration of penicillin-binding proteins, and efflux pumps.
See Also[edit]
- Cefaclor (2nd)
- Cefadroxil (1st)
- Cefdinir (3rd)
- Cefditoren (3rd)
- Cefixime (3rd)
- Cefpodoxime (3rd)
- Cefprozil (2nd)
- Ceftibuten (1st)
- Cephalexin (1st)
- Cefuroxime (2nd)
- Cephradine (1st)
- Loracarbef (2nd)
- Cefazolin (1st)
- Cefepime (4th)
- Cefoperazone (3rd)
- Cefotaxime (3rd)
- Cefoxitin (2nd)
- Ceftaroline (5th)
- Ceftazidime (3rd)
- Ceftibuten (3rd)
- Ceftizoxime (3rd)
- Ceftolozane/Tazobactam (5th)
- Cefuroxime (2nd)
- Cephradine (1st)
- Ceftriaxone (3rd)
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
